SEC Form 4 · accession 0001144204-15-022106
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Krishna Yeshwant
Director · 10% Owner
Period of report
Apr 7, 2015
Accepted (ET)
Apr 9, 2015 · 6:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 7, 2015 | U | 923,735 | $50.00 | D | 220,917 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Solely as a result of the Investor Rights Agreement filed as Exhibit 4.1 of the Form 8-K filed by Issuer with the Securities and Exchange Commission on January 12, 2015, the Reporting Person may be deemed to have beneficial ownership of the (a) 20,604,288 shares directly held by Roche Holdings, Inc., an indirect wholly owned subsidiary of Roche Holding Ltd ("Roche"), (b) 414,823 shares directly held by Roche Finance Ltd, a wholly owned subsidiary of Roche and (c) approximately 950,956 shares held by Third Rock Ventures, L.P. ("TRV"). The estimated ownership of Google Ventures 2011, L.P. and TRV reported herein is based on the preliminary results of a tender offer disclosed in Amendment No. 6 to Schedule TO filed by Roche with the Securities and Exchange Commission on April 7, 2015.
- F2These shares are directly held by Google Ventures 2011, L.P. The general partner of Google Ventures 2011, L.P. is Google Ventures 2011 GP, L.L.C. The Reporting Person is a partner at an affiliate of Google Ventures 2011 GP, L.L.C. and disclaims beneficial ownership of all shares except to the extent of his pecuniary interest, if any, therein.